Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Trading Statement

11 Aug 2009 07:00

RNS Number : 2015X
S & U PLC
11 August 2009
 



11 August 2009

S & U PLC ("S&U" or "the Company")

Trading update

Notice of Results

S&U, Britain's foremost niche home credit and motor finance provider, today announces a trading update for the six months to 31 July. The Company is pleased to announce that it is currently trading in line with market expectations and intends issuing its Interim results on 24 September 2009. 

HOME CREDIT

Current trading and profitability within our home credit division is very satisfactory and is encouraging for the full year outlook.

A more cautious sales and underwriting environment in the last six months has nevertheless seen a steady increase in customer numbers on shorter-term loan agreements and therefore more flexible book debt. This has been reflected in an improvement in collections quality and impairment against last year. Tight expense and overhead control has seen this represented in improved profitability; returning customer confidence should therefore see further profit advances in the second half of this financial year.

MOTOR FINANCE

Advantage Finance, our motor finance business which comprises just over 30% of Group revenue, continues to trade well and to exceed budget. Whilst applications continue to grow, a strict and prudent underwriting policy has seen revenue fall slightly by 4%, but overall collections are slightly ahead on stable book debt. Advantage continues to broaden its product range into the non-prime market and has seen significant improvements in debt quality as a result.

Although early redemptions are still lower than a year ago, borrowings are significantly lower too, thus allowing headroom for expansion in both its traditional sub-prime and newer non-prime markets.

FUNDING AND CAPITAL

In uncertain times, S&U's treasury and funding position is strong and continuing to strengthen. Gearing and borrowings are both less than last year, the latter by more than £4 m. Our medium term finance and overdraft facilities give us the potential for organic growth and careful acquisitions, particularly in the home credit sector.

OUTLOOK

As predicted S&U's trading has remained strong and the Company has strengthened its balance sheet, despite a particularly volatile and uncertain time in the economic cycle, Current trends suggest further progress in the second half, and a business performance which reflects the robust nature of our business model in the challenging economic environment.

Commenting, Mr Anthony Coombs, S&U Chairman, said:

"Trading is in line in the first half and the outlook for the full year remains positive".

For further information please contact:

S&U plc www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777 

 

Charles Stanley Securities 

Mark Taylor / Freddy Crossley 020 7149 6000 

 

Smithfield 

Reg Hoare / Rebecca Whitehead 020 7360 4900 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDIRUBGGCG
Date   Source Headline
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results
17th Jan 20222:39 pmRNSAppointment of non-executive director
17th Jan 20222:33 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSTrading Statement
7th Dec 20217:00 amRNSBlock Listing Application
23rd Nov 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
29th Oct 20219:46 amRNSDirector/PDMR Shareholding
6th Oct 20217:00 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim Results
22nd Sep 20217:00 amRNSInvestor Presentation
10th Aug 20217:00 amRNSTrading Update and Notice of Results
23rd Jul 20214:50 pmRNSDirector/PDMR Shareholding
30th Jun 20214:02 pmRNSDirector/PDMR Shareholding
24th May 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 202110:00 amRNSResult of AGM
20th May 20217:00 amRNSAGM Statement and Trading Update
23rd Apr 20211:00 pmRNSAnnual Report and Accounts
16th Apr 20215:37 pmRNSDirector/PDMR Shareholding and Total Voting Rights
14th Apr 20219:54 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.